Sanofi-Pasteur

News

Sanofi snaps up acne vaccine developer Origimm Bio

Sanofi has added to its vaccine pipeline with an agreement to acquire Austria's Origimm Biotechnology and its vaccine-based immunotherapy for people with acne.

News

Sanofi and Translate Bio expand mRNA vaccine agreement

Sanofi’s Pasteur vaccines unit and Translate Bio have expanded a collaboration to develop mRNA-based vaccines across all infectious disease areas.

News

David Loew swaps Sanofi’s top vaccine job for CEO role at Ip...

Sanofi had no sooner announced the departure of David Loew, its head of vaccines, before he surfaced as the new chief executive of French specialty drugmaker Ipsen, taking over

News

Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio

Sanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop an mRNA vaccine against the coronavirus that causes the COVID-19 pandemic.

News